Elevated cardiac troponin I levels had prognostic value for paroxysmal supraventricular tachycardias only when the condition was associated with a history of coronary artery disease.
Active myocarditis stage was found to predict the recurrence of ventricular tachycardia (VT) in patients with myocarditis undergoing VT ablation.
The RhythmiaTM 3D mapping system coupled with a new nonfluoroscopic approach that reduces exposure to radiation was found to be safe, effective, and well tolerated during arrhythmia ablation procedures.
In patients with abnormal vital signs presenting to the emergency department who are suspected of having a pulmonary embolism, a negative focused cardiac ultrasound examination may be associated with reduced odds of a pulmonary embolism diagnosis.
Investigators assessed the diagnostic value of a new ECG algorithm according to the morphologic traits of the QRS on the limb leads.
A novel voltage-independent high-density mapping display can identify the functional substrate for ventricular tachycardia during sinus rhythm and guide targeted ablation.
The presence of COPD is linked to higher all-cause mortality and cardiac death at 24 hours in high-risk patients who present with ventricular tachyarrhythmias and sudden cardiac arrest.
Patients with higher levels of thyroid-stimulating hormone were more likely to experience atrial tachyarrhythmia after catheter ablation for atrial fibrillation.
A 56-year-old man with improved flu-like symptoms, but marked shortness of breath and palpitations, presents to an urgent care center.
The burden of ventricular tachycardia can be reduced with noninvasive mapping of cardiac arrhythmias and noninvasive delivery of ablative radiation
